Similar Accuracy and Patient Experience with Different One Step Ovulation Predictor Kits.

luteinizing hormone menstrual cycle ovulation ovulation predictor kit patient experience

Journal

Fertility and sterility
ISSN: 1556-5653
Titre abrégé: Fertil Steril
Pays: United States
ID NLM: 0372772

Informations de publication

Date de publication:
24 Sep 2024
Historique:
received: 12 06 2024
revised: 13 09 2024
accepted: 16 09 2024
medline: 27 9 2024
pubmed: 27 9 2024
entrez: 26 9 2024
Statut: aheadofprint

Résumé

To examine the accuracy of five different at home ovulation predictor kits (OPKs), and to understand patient experience with the use of those kits. Prospective cohort study. Single academic fertility practice. Patients with regular menses undergoing monitored natural cycle frozen embryo transfer, timed intercourse, and intrauterine insemination cycles involving daily blood luteinizing hormone (LH) level monitoring between 2022 and 2024. Use of five commercially available OPKs for the first five days of blood LH monitoring with a daily experience survey. The primary outcome was accuracy of the ovulation predictor kits defined as concordance between test result (positive or negative) and blood LH level (above or below 25mIU/ml). Secondary outcomes included positive predictive value, negative predictive value, sensitivity, and specificity of OPK surge detection. We also examined patient report regarding clarity of kit instructions, confidence in kit results, and likelihood of future purchase and use. 23 patients completed 97 total days of ovulation predictor kit testing and 13 patients had a documented blood LH surge during their testing. OPK surge detection accuracy when compared to blood LH surge was similar across the five kits (Easy@Home 95.88%, Wondfo 94.85%, Pregmate 96.90%, Clearblue 91.75%, Clinical Guard 91.75%, p-value 0.06). Sensitivity was slightly better for Easy@ Home (75.00%), Wondfo (69.23%) and Pregmate (76.92%) than for Clearblue (61.54%) and Clinical Guard (38.46%). There were no clinically significant differences between the five OPKs regarding positive predictive value, negative predictive value, or specificity of surge detection. Participant experience was qualitatively similar across all five OPKs with exception of slightly fewer patients reporting that they were likely to purchase and use Clinical Guard again in the future. All five tested at home one step OPKs were highly accurate and performed similarly regarding patient experience despite variation in price.

Identifiants

pubmed: 39326629
pii: S0015-0282(24)02246-5
doi: 10.1016/j.fertnstert.2024.09.031
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Anna Vanderhoff (A)

Center for Infertility and Reproductive Surgery, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: anna.c.vanderhoff@gmail.com.

Andrea Lanes (A)

Center for Infertility and Reproductive Surgery, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.

Ian Waldman (I)

Colorado Center for Reproductive Medicine Fertility of Miami, Miami, FL, USA.

Elizabeth Ginsburg (E)

Center for Infertility and Reproductive Surgery, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.

Classifications MeSH